Trials / Completed
CompletedNCT01796587
Non-Interventional Study Among Users Of LoFric Origo
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 423 (actual)
- Sponsor
- Wellspect HealthCare · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: To evaluate compliance of LoFric Origo in a general intermittent catheterization (IC) population with the use of LoFric Origo, by means of a subjective assessment scale Secondary objectives: * To evaluate the subject's perception associated with the use of the LoFric Origo, by means of a subjective assessment scale * To evaluate the subject's discomfort associated with the use of the LoFric Origo, by means of a subjective assessment scale * To observe and collect data on bladder regimen/IC frequency by assessments of descriptive data of demography, catheter therapy, history and other patient reported outcomes. Study Design: Non-interventional study, multicentre, prospective study. Target Subject Population: General intermittent catheterization, LoFric Origo male users. Medical Device: LoFric Origo Study Variable(s): * Primary variable: Use or No use of LoFric Origo after 8 weeks. * Secondary variable(s): patient reported questionnaire with regards to perception, discomfort, diagnose, health status, catheter history and other patient reported outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LoFric Origo |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-03-01
- First posted
- 2013-02-22
- Last updated
- 2015-05-08
Locations
19 sites across 6 countries: Belgium, France, Netherlands, Norway, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01796587. Inclusion in this directory is not an endorsement.